课题基金 / 基金详情

Clinical usefulness and application of Taxol-resisitance molecules

Clinical usefulness and application of Taxol-resisitance molecules
紫杉醇抗性分子的临床用途和应用
批准号:
20592014
负责人:
MASUYAMA Keisuke
金额:
$2.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

MASUYAMA Keisuke的其他基金

相似基金

相关文献

中文摘要
翻译
We found that head and neck cancer stem cells appeared to be resistant to the treatment of anti-cancer drugs。We did not find any differences of TRAG-3mRNA expressions between CD44+and CD44-cells of head and neck cancer cell lines。In addition,CD44+cells significantly suppressed T cell proliferation。As for cytokine production,IFN·was reduced,however,IL-10was increased when co-cultured with CD44+cells.Thus,immunosuppressive mechanisims other than TRAG-3expression may have a role for anti-cancer drug resistance。
英文摘要
We found that head and neck cancer stem cells appeared to be resistant to the treatment of anti-cancer drugs. We did not find any differences of TRAG-3 mRNA expressions between CD44+ and CD44- cells of head and neck cancer cell lines. In addition, CD44+ cells significantly suppressed T cell proliferation. As for cytokine production, IFN・was reduced, however, IL-10 was increased when co-cultured with CD44+ cells. Thus, immunosuppressive mechanisims other than TRAG-3 expression may have a role for anti-cancer drug resistance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [近松一朗, 他, 森山元大,増山敬祐]
通讯作者: 森山元大,増山敬祐
Th1/Th2 CD4+ T helper responses against wild-type sequence p53 peptides in HLA-DP5 patients with head and neck cancer
头颈癌 HLA-DP5 患者中 Th1/Th2 CD4 T 辅助细胞对野生型序列 p53 肽的反应
DOI: --
发表时间: 2008
期刊:
影响因子: --
作者: [Chikamatsu K, et al.]
通讯作者: et al.
Expression of VEGF-C in oral squamous cell carcinoma correlates with sentinel lymph node lymphangiogenesis.
口腔鳞状细胞癌中 VEGF-C 的表达与前哨淋巴结淋巴管生成相关。
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [石井裕貴, 近松一朗, 坂倉浩一, 宮田政則,古屋信彦, 増山敬祐.]
通讯作者: 増山敬祐.
DOI: --
发表时间: 2009
期刊: Oral Oncol (in press)
影响因子: --
作者: [Okamoto A, et al.]
通讯作者: et al.
共 39 条
    Development of dendritic cell-based cancer chemoimmunotherapy in head and neck caner to target inflammatory tumor microenvironment
    • 批准号:
      15K10806
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2015
    • 负责人:
      MASUYAMA Keisuke
    • 依托单位:
    Establishment of DC immunotherapy with low-dose chemotherapy in HNSCC
    • 批准号:
      24592592
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2012
    • 负责人:
      MASUYAMA Keisuke
    • 依托单位:
    Molecular biological analysis of eosinophilic sinusitis and otitis media
    海外基金